TY - JOUR
T1 - National cancer control plans in Latin America and the Caribbean
T2 - challenges and future directions
AU - Villarreal-Garza, Cynthia
AU - Aranda-Gutierrez, Alejandro
AU - Gonzalez-Sanchez, David G.
AU - Bragança-Xavier, Camila
AU - Negrete-Tobar, Gabriela
AU - Chavarri-Guerra, Yanin
AU - Mohar, Alejandro
AU - Barrios, Carlos
AU - Coutinho, Anelisa
AU - Jamal, Ahmedin
AU - Hricak, Hedvig
AU - Loehrer, Patrick
AU - Moraes, Fabio Ynoe
AU - Murillo, Raúl
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/6
Y1 - 2025/6
N2 - In this Policy Review, we examine cancer incidence and mortality rates across Latin America and the Caribbean, focusing on national cancer control plans (NCCPs) as frameworks for reducing the cancer burden in the region. By 2022, only 16 countries had active NCCPs, with eight being cancer specific and eight being integrated into public health plans. Our analysis found that dedicated NCCPs were linked to reduced cancer incidence but not reduced mortality. Broader socioeconomic indicators, such as universal health coverage and a higher Human Development Index, were more strongly associated with improved cancer outcomes, including reduced mortality-to-incidence ratios. Prevention measures such as cervical cancer screening and compliance with WHO's MPOWER tobacco control strategies also reduced cancer incidence, underscoring the importance of public health policies. However, challenges including insufficient cancer registries, underfunding, and health-care inequities hinder NCCP implementation. Addressing these gaps requires sustainable registries, regional evaluation frameworks, global collaboration, and stronger political commitment to ensure the success of NCCPs.
AB - In this Policy Review, we examine cancer incidence and mortality rates across Latin America and the Caribbean, focusing on national cancer control plans (NCCPs) as frameworks for reducing the cancer burden in the region. By 2022, only 16 countries had active NCCPs, with eight being cancer specific and eight being integrated into public health plans. Our analysis found that dedicated NCCPs were linked to reduced cancer incidence but not reduced mortality. Broader socioeconomic indicators, such as universal health coverage and a higher Human Development Index, were more strongly associated with improved cancer outcomes, including reduced mortality-to-incidence ratios. Prevention measures such as cervical cancer screening and compliance with WHO's MPOWER tobacco control strategies also reduced cancer incidence, underscoring the importance of public health policies. However, challenges including insufficient cancer registries, underfunding, and health-care inequities hinder NCCP implementation. Addressing these gaps requires sustainable registries, regional evaluation frameworks, global collaboration, and stronger political commitment to ensure the success of NCCPs.
UR - https://www.scopus.com/pages/publications/105006697939
U2 - 10.1016/S1470-2045(25)00039-7
DO - 10.1016/S1470-2045(25)00039-7
M3 - Review article
AN - SCOPUS:105006697939
SN - 1470-2045
VL - 26
SP - e320-e330
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 6
ER -